Marie Irlès-Depé

ORCID: 0000-0003-1487-7287
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Liver Disease Diagnosis and Treatment
  • Liver Disease and Transplantation
  • Liver Diseases and Immunity
  • Hepatitis C virus research
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Inflammatory Bowel Disease
  • Diet, Metabolism, and Disease
  • Cannabis and Cannabinoid Research
  • Autoimmune and Inflammatory Disorders
  • Gastrointestinal Tumor Research and Treatment
  • Diverticular Disease and Complications
  • Advanced MRI Techniques and Applications
  • Eosinophilic Esophagitis
  • Microscopic Colitis
  • Alcohol Consumption and Health Effects
  • Pediatric Hepatobiliary Diseases and Treatments
  • Gallbladder and Bile Duct Disorders
  • Viral gastroenteritis research and epidemiology
  • Radiomics and Machine Learning in Medical Imaging
  • Ultrasound Imaging and Elastography
  • Pancreatitis Pathology and Treatment
  • Medical Imaging Techniques and Applications
  • Gastrointestinal disorders and treatments

Hôpital Cardiologique du Haut-Lévêque
2018-2023

Centre Hospitalier Universitaire de Bordeaux
2018-2022

Inserm
2021-2022

Université de Bordeaux
2021-2022

SomaLogic (United States)
2022

Institut Universitaire de Recherche Clinique
2022

Bordeaux Population Health
2021

Hôpital Pellegrin
2020

KU Leuven
2018

Background and Aims: The European Association for the Study of Liver (EASL) has recently proposed an algorithm diagnosis advanced liver fibrosis. We aimed to evaluate diagnostic accuracy this in nonalcoholic fatty disease (NAFLD). Approach Results: One thousand fifty‐one patients with NAFLD, biopsy, four noninvasive tests (NITs; Fibrosis‐4 [FIB4], vibration controlled transient elastography [VCTE], FibroMeter, Fibrotest) were included. enhanced fibrosis (ELF) score was available 396...

10.1002/hep.32665 article EN Hepatology 2022-07-13

The combination of laboratory and elastography tests allows the accurate diagnosis advanced liver fibrosis in patients with NAFLD. In this study, we compared diagnostic performances a two-step strategy (laboratory vibration-controlled transient [VCTE] or two-dimensional shear-wave SuperSonic Imagine [2D-SWE-SSI]) added value three-step two methods).From prospective registry, retrospectively selected 577 consecutive suspicion NAFLD who underwent to calculate Fibrosis-4 (FIB-4) score,...

10.1002/hep.31655 article EN Hepatology 2020-11-25

The boundary between non-alcoholic (NAFLD) and alcohol-related liver disease (ALD) is based on alcohol consumption. However, metabolic syndrome use frequently co-exist. aim of this study was to determine prognostic factors long-term morbidity mortality in patients with NAFLD or ALD.From 2003 2016, all consecutive ALD were prospectively included cohort study. We evaluated overall survival, specific cause occurrence any complication. primary endpoint analysed by the Kaplan Meier method,...

10.1111/liv.15081 article EN Liver International 2021-10-22

Unlike for advanced liver fibrosis, the practical rules early non-invasive diagnosis of cirrhosis in NAFLD remain not well defined. Here, we report derivation and validation a stepwise diagnostic algorithm 1568 patients with biopsy coming from four independent cohorts. The study algorithm, using first elastography-based tests Agile3+ Agile4 then specialized blood FibroMeterV3G CirrhoMeterV3G, provides stratification groups, last which is enriched (71% prevalence set). A risk prediction chart...

10.1038/s41467-023-40328-4 article EN cc-by Nature Communications 2023-08-26

Non-invasive assessment of fibrosis is predictive the prognosis non-alcoholic and alcoholic fatty liver disease but this has not been demonstrated in metabolic (dysfunction)-associated (MAFLD).We assessed non-invasive methods patients with MAFLD.All consecutive MAFLD, stiffness measurements, FIB-4 (Fibrosis-4), LIVERFASt were included cohort study. The primary endpoint was analysed by Kaplan-Meier method secondary endpoints estimated Gray test or logistic regression. Factors independently...

10.1111/apt.16760 article EN Alimentary Pharmacology & Therapeutics 2022-01-03

Approximately 80% of patients with primary sclerosing cholangitis (PSC) also have inflammatory bowel disease (IBD), and its effect on the outcomes liver transplantation (LT) for PSC is unclear. We retrospectively collected data from adults who underwent LT 1989 to January 2018 in 4 French centers. compared rates patient graft survivals complications after LT. Among 87 patients, 52 (60%) had preexisting IBD. Excluding those died within first 3 months, 10‐year survival were 92.6% (95%...

10.1002/lt.25838 article EN Liver Transplantation 2020-06-30
Tangui Barré Stanislas Pol Clémence Ramier Vincent Di Beo Fabrice Carrat and 95 more Morgane Bureau Marc Bourlière Céline Dorival Lawrence Serfaty Tarik Asselah Jérôme Boursier Fabienne Marcellin Patrizia Carrieri Hélène Fontaine Camélia Protopopescu Laurent Alric Delphine Bonnet Virginie Payssan-Sicart Chloe Pomes Fabien Zoulim Marianne Maynard Roxane Bai Lucie Hucault François Bailly François Raffi Eric Billaud D. Boutoille Maeva Lefebvre Elisabeth André‐Garnier Paul Calès I. Hubert Adrien Lannes F. Lunel Nathalie Boyer Nathalie Giuily Corinne Castelnau Giovanna Scoazec Emilie Rousseaud Anaïs Vallet‐Pichard Philippe Sogni Victor de Lédinghen Juliette Foucher Jean‐Baptiste Hiriart Jancell M’Bouyou Marie Irlès-Depé Si Nafa Si Ahmed Valérie Oulès Albert Tran Rodolphe Anty Ève Gelsi Régine Truchi Dominique Thabut Saloua Hammeche Joseph Moussali Xavier Causse Barbara De Dieuleveult Brahim Ouarani Damien Labarrière Nathalie Ganne‐Carrié Véronique Grando–Lemaire Pierre Nahon Séverine Brulé Betul Ulker Dominique Guyader Caroline Jézéquel Audrey Brener Anne Laligant Aline Rabot Isabelle Renard François Habersetzer Thomas F. Baumert Michel Doffoël Catherine Schmidt‐Mutter Pauline Simo‐Noumbissie Esma Razi Jean-Pierre Bronowicki Hélène Barraud Mouni Bensenane Abdelbasset Nani Sarah Hassani-Nani Marie-Albertine Bernard Georges‐Philippe Pageaux Dominique Larrey M Mészáros Sophie Métivier Christophe Bureau Thibault Morales Jean Marie Péron Marie Angèle Robic Thomas Decaens Marine Faure Bruno Froissart Marie‐Noëlle Hilleret Jean–Pierre Zarski Ghassan Riachi Odile Goria Fatima Paris Hélène Montialoux Vincent Leroy Giuliana Amaddeo

Background: Chronic hepatitis B virus (HBV) infection may evolve into cirrhosis and hepatocellular carcinoma, this progression be accelerated by specific risk factors, including overweight obesity. Although evidence for a protective effect of cannabis use on elevated body weight has been found other populations, no data are available HBV-infected patients. Aims: We aimed to identify factors (including use) obesity in patients with HBV chronic infection. Methods: Using baseline from the...

10.1089/can.2021.0094 article EN Cannabis and Cannabinoid Research 2021-10-14
Patrizia Carrieri Marc Bourlière Vincent Di Beo Clovis Lusivika‐Nzinga Clémence Ramier and 95 more Saskia Antwerpes Camélia Protopopescu Jean‐Marc Lacombe Stanislas Pol Hélène Fontaine Abbas Mourad Fabrice Carrat Martin Duracinský Fabienne Marcellin Laurent Alric Delphine Bonnet Océane Camou Fabien Zoulim Marianne Maynard François Bailly Bénédicte Poumaroux Miroslava Subic F. Raffi Éric Billaud D. Boutoille Maeva Lefebvre Elisabeth André‐Garnier Paul Calès I. Hubert Clémence M. Canivet F. Lunel Jérôme Boursier Tarik Asselah Nathalie Boyer Nathalie Giuily Corinne Castelnau Giovanna Scoazec Stanislas Pol Hélène Fontaine Lucia Parlati Emilie Rousseaud Anaïs Vallet‐Pichard Philippe Sogni Victor de Lédinghen Juliette Foucher Jean‐Baptiste Hiriart Paul Hermabessière Marie Irlès-Depé Marc Bourlière Si Nafa Si Ahmed Valérie Oulès Rania Kibeche Albert Tran Rodolphe Anty Ève Gelsi Régine Truchi Dominique Thabut Saloua Hammeche Joseph Moussali Xavier Causse Barbara De Dieuleveult Brahim Ouarani Damien Labarrière Magali Jeulin Nathalie Ganne‐Carrié Véronique Grando–Lemaire Pierre Nahon Séverine Brulé Lucie Del Pozo Caroline Jézéquel Audrey Brener François Habersetzer Thomas F. Baumert Lawrence Serfaty Pauline Simo‐Noumbissie Alexandre Bolle Jean‐Pierre Bronowicki Mouni Bensenane-Oussalah Vincent Haghnejad Sébastien Daude Sarah Hadj-Rhouma Georges‐Philippe Pageaux Dominique Larrey M Mészáros Sophie Métivier Christophe Bureau Thibault Morales Jean Marie Péron Hélène Larrue Thomas Decaens Marie‐Noëlle Hilleret Charlotte Costentin Bleuenn Brusset Agnès Bonadona Ghassan Riachi Odile Goria Fatima Paris Hélène Montialoux Vincent Leroy Giuliana Amaddeo

10.1007/s11136-023-03496-w article EN Quality of Life Research 2023-08-16

The Rutgeerts’ score (RS) is used to guide management of patients with Crohn’s disease (CD) after ileal resection ileo-colonic anastomosis. modified RS differentiates lesions at the anastomosis ±<5 isolated neo-terminal erosions (i2a) from presence ≥5 ± anastomotic (i2b). We investigated if clinical relapse (CR) and need for new endoscopic/surgical intervention (NI) differ between i2a i2b endoscopic recurrence (ER). Our secondary objective was evaluate effect therapy modification based on...

10.1093/ecco-jcc/jjx180.788 article EN Journal of Crohn s and Colitis 2018-01-16
Tangui Barré Fabrice Carrat Clémence Ramier Hélène Fontaine Vincent Di Beo and 95 more Morgane Bureau Céline Dorival Dominique Larrey Elisabeth Delarocque‐Astagneau Philippe Mathurin Fabienne Marcellin Ventzislava Petrov–Sanchez Carole Cagnot Patrizia Carrieri Stanislas Pol Camélia Protopopescu Laurent Alric Chloe Pomes Fabien Zoulim Marianne Maynard Roxane Bai Lucie Hucault François Bailly F. Raffi Eric Billaud D. Boutoille Maeva Lefebvre Elisabeth André‐Garnier Paul Calès I. Hubert Adrien Lannes F. Lunel Jérôme Boursier Tarik Asselah Nathalie Boyer Nathalie Giuily Corinne Castelnau Giovanna Scoazec Stanislas Pol Hélène Fontaine Emilie Rousseaud Anaïs Vallet‐Pichard Philippe Sogni Victor de Lédinghen Juliette Foucher Jean‐Baptiste Hiriart Jancell M’Bouyou Marie Irlès-Depé Marc Bourlière Si Nafa Si Ahmed Valérie Oulès Albert Tran Rodolphe Anty Ève Gelsi Régine Truchi Dominique Thabut Saloua Hammeche Joseph Moussali Xavier Causse Barbara De Dieuleveult Brahim Ouarani Damien Labarrière Nathalie Ganne‐Carrié Véronique Grando–Lemaire Pierre Nahon Séverine Brulé Betul Ulker Dominique Guyader Caroline Jézéquel Audrey Brener Anne Laligant Aline Rabot Isabelle Renard François Habersetzer Thomas F. Baumert Michel Doffoël Catherine Schmidt‐Mutter Pauline Simo‐Noumbissie Esma Razi Jean-Pierre Bronowicki Hélène Barraud Mouni Bensenane Abdelbasset Nani Sarah Hassani-Nani Marie-Albertine Bernard Georges‐Philippe Pageaux Dominique Larrey M Mészáros Sophie Métivier Christophe Bureau Thibault Morales Jean Marie Péron Marie Angèle Robic Thomas Decaens Marine Faure Bruno Froissart Marie‐Noëlle Hilleret Jean–Pierre Zarski Ghassan Riachi Odile Goria

Patients with chronic hepatitis C virus (HCV) infection are at greater risk of developing metabolic disorders. Obesity is a major factor for these disorders, and therefore, managing body weight crucial. Cannabis use, which common in patients, has been associated lower corpulence various populations. However, this relationship not yet studied persons HCV infection.Using baseline data from the French ANRS CO22 Hepather cohort, we used binary logistic multinomial regression models to test an...

10.1186/s42238-022-00138-9 article EN cc-by Journal of Cannabis Research 2022-06-11

Background: Screening T2DM for NASH fibrosis using specific markers is mandatory, as liver enzymes are often normal despite advanced fibrosis. LIVERFASt (LF), a serum marker with CPT code assessing (LF-Fib), activity and steatosis had high performance identifying severe in T2DM.Aim: To demonstrate that LF-Fib an alternative to biopsy (LB) the estimation of transition rate [F1 stage or more (TRF1)], NAFLD better performances than transient elastography (TE) FIB4.Methods: TRF1 was evaluated...

10.2337/db21-76-or article EN Diabetes 2021-06-01
Coming Soon ...